Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Amplifi Vein Dilation System Treatment on Radiocephalic AVF Maturation-3

NCT07058610 is registered in ClinicalTrials.gov with Amplifi Vascular, Inc. as lead sponsor.

NCT NCT07058610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07058610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Amplifi Vein Dilation System Treatment on Radiocephalic AVF Maturation-3
Lead sponsor
Amplifi Vascular, Inc.
Phase
Not applicable
Overall status
Completed
Start date
December 8, 2020
Completion date
June 11, 2025
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage renal disease requiring haemodialysis